Intelligence / Healthtech & medtech market map / Life-science tools, instruments and laboratory services / Laboratory consumables and reagents / Clinical-development sample handling and biobanking consumables
Clinical-development sample handling and biobanking consumables
Single-use sample collection, cryovials, storage plates, aliquot bags, shipping containers, filtration and general laboratory chemicals bought by pharmaceutical clinical-development functions and their CRO partners to collect, process, store and ship clinical trial samples. Segmented by buyer organisation type (pharma clinical development and clinical-stage CROs) and the job of maintaining sample integrity from collection through biobanking. Excludes discovery assay work (niche 1), scale-up purification (niche 2), routine contract QC (niche 3) and academic research (niche 4).
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Clinical development and clinical operations functions of pharmaceutical and biotechnology companies; clinical-stage CRO sample-management teams
- Buying centre
- Clinical operations or biobanking manager owns the workflow; sourcing handled by clinical supply chain or category procurement, frequently through validated vendor lists and quality-agreement review; quality assurance and regulatory affairs approve specifications
- Start-up of a new clinical trial or new country sites, triggering a fresh sample-handling basket
- Expansion into new indications or new therapeutic modalities with different sample matrices
- Biobanking build-out or migration to centralised sample storage
- Regulatory or data-integrity findings requiring validated, traceable sample containers and records
- Sample integrity failures (haemolysis, adsorption, temperature excursion) that can invalidate a whole biobank
- Strict validation and quality-agreement requirements lengthening vendor onboarding
- Multi-site standardisation gaps producing inconsistent sample handling across countries
- Batch and expiry management complexity across long-duration, multi-year studies
How this was sized
$9.0B ($7.2B–$10.8B) · 2026 · Bottom-up
Parent pool 2026 USD 60.4B (Emergen tools & reagents 2026 USD 109.77B [3] x 55% consumables-and-reagents share assumption; cross-check GVR 2026 USD 202.6B [1] x 30% = USD 60.8B; parent range USD 48-72B). Niche = parent x 15% assumed clinical sample-handling share = USD 9.1B, rounded to USD 9.0B; range USD 7.2-10.8B (parent range x 15%). Forecast: 9.0 x 1.06^5 = USD 12.0B by 2031, CAGR aligned with the 6.0% tools & reagents CAGR [3] and the 6.6% CAGR cited for the life science tools market in the HKEX industry overview [4].
- Life Science Tools Market Size & Share Report, 2026-2033
grandviewresearch.com · 2026-09-10 - Life Science Tools & Reagents Market Size, Share & Trends | Industry Report 2035
emergenresearch.com · 2025-12-01 - INDUSTRY OVERVIEW - hkexnews.hk
www1.hkexnews.hk · 2026-09-30 - Life Science Tools Market Size, Share, Drivers Report 2026-2030
thebusinessresearchcompany.com · 2026-09-13
Alongside it in Laboratory consumables and reagents
// Sell into Clinical-development sample handling and biobanking consumables